The COVID-19 vaccines currently being administered under FDA-granted emergency use authorizations are produced by Pfizer, Moderna and Johnson & Johnson. In May, Pfizer applied for its vaccine’s full approval. Moderna did the same in June.
To many, the FDA’s emergency use authorization indicates Americans should have the option to refuse whether to receive treatment. Current and former federal health officials told NBC News full FDA approval would allow more businesses and institutions to require COVID-19 vaccination, which could mean an influx of vaccinations among Americans who have yet to receive their shot.
“I think once the vaccines go through full FDA approval, everything should be on the table, and I think that everything will be on the table at the level of municipalities, states, employers, venues, government agencies,” said Andy Slavitt, who stepped down from his role as senior advisor to the White House COVID-19 Response Team in June.
Mr. Slavitt also said government agencies “ought to rethink what’s appropriate” after full FDA approval, as many COVID-19 vaccine survey respondents say they will only get vaccinated if they’re required.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
